Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cardio Kapilar with Coenzyme Q10 is a multi-ingredient dietary supplement developed by the Russian company Diod, designed to support cardiovascular health and improve microcirculation. The formulation combines dihydroquercetin, coenzyme Q10 (ubiquinone), vitamin C, and selenium. Dihydroquercetin serves as a potent antioxidant and vasoprotector that helps maintain capillary integrity and blood flow. Coenzyme Q10 is a critical component of the mitochondrial electron transport chain, facilitating energy production within myocardial cells. Clinical evaluations conducted in patients with ischemic heart disease and those recovering from myocardial infarction or bypass surgery suggest that the supplement acts as an effective adjunct to primary therapy, helping to reduce symptoms of cardiac and respiratory insufficiency while shortening rehabilitation periods.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cardio Kapilar with Coenzyme Q10.